S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Baker Bros Advisors/Q3 2021

Baker Bros Advisors

Periodo: Q3 2021 Β· Depositato: 2021-11-15
Vedi su SEC EDGAR β†—
AUM
$22.77B
Valore totale del portafoglio
Posizioni
122
Titoli dichiarati
Prima Posizione
SGEN
35.3% $8.03B
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2021-11-15) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
SGENSeagen Inc.$8.03B35.26%β€”β€”
35.3%
ONCBeiGene, Ltd.$4.24B18.60%$363.00$297.65-18.0%
18.6%
INCYIncyte Corporation$2.20B9.67%$68.78$116.86+69.9%
9.7%
KODKodiak Sciences Inc.$1.41B6.19%$95.98$38.54-59.9%
6.2%
ASNDAscendis Pharma A/S$723.9M3.18%$159.39$274.50+72.2%
3.2%
ACADACADIA Pharmaceuticals Inc.$696.1M3.06%$16.61$25.97+56.4%
3.1%
BMRNBioMarin Pharmaceutical Inc.$589.0M2.59%$77.29$58.99-23.7%
2.6%
ARGXargenx SE$338.1M1.48%$302.00$939.68+211.2%
1.5%
PRLDPrelude Therapeutics Inc.$316.4M1.39%$31.25$4.91-84.3%
1.4%
NVTAQInvitae Corporation$280.7M1.23%β€”β€”
1.2%
MRTXMirati Therapeutics, Inc.$249.4M1.10%β€”β€”
1.1%
ABCLAbCellera Biologics Inc.$209.4M0.92%$20.04$8.11-59.5%
0.9%
IGMSIGM Biosciences, Inc.$207.5M0.91%β€”β€”
0.9%
BCRXBioCryst Pharmaceuticals, Inc.$182.7M0.80%$14.37$9.84-31.5%
0.8%
KYMRKymera Therapeutics, Inc.$140.1M0.62%$58.74$113.51+93.2%
0.6%
PACBPacific Biosciences of California, Inc.$139.1M0.61%$25.55$1.68-93.4%
0.6%
MDGLMadrigal Pharmaceuticals, Inc.$119.6M0.53%$79.79$528.10+561.9%
0.5%
LEGNLegend Biotech Corporation$119.5M0.52%$50.56$29.91-40.8%
0.5%
AMRNXXXXAmarin Corporation plc$111.5M0.49%β€”β€”
0.5%
IMCRImmunocore Holdings plc$93.4M0.41%$37.07$32.50-12.3%
0.4%
HRTXHeron Therapeutics, Inc.$86.9M0.38%$10.69$0.44-95.9%
0.4%
CERSCerus Corporation$83.5M0.37%$6.09$3.16-48.1%
0.4%
GBTGlobal Blood Therapeutics, Inc.$82.0M0.36%β€”β€”
0.4%
ALLKAllakos Inc.$74.4M0.33%β€”β€”
0.3%
NRIXNurix Therapeutics, Inc.$73.5M0.32%$29.96$23.97-20.0%
0.3%
DBVTDBV Technologies S.A.$71.6M0.31%$9.80$15.82+61.4%
0.3%
TILInstil Bio, Inc.$69.6M0.31%$357.50$7.73-97.8%
0.3%
VERVVerve Therapeutics, Inc.$66.6M0.29%β€”β€”
0.3%
VSTMXXXXVerastem, Inc.$66.2M0.29%β€”β€”
0.3%
HZNPHorizon Therapeutics Public Ltd Co$65.6M0.29%β€”β€”
0.3%

AttivitΓ  Trimestre su Trimestre

Q3 2021 vs. Q2 2021

Nuove Posizioni (8)

TickerEmittenteNozionale
DICEDICE Therapeutics, Inc.$19.3M
SRZNSurrozen, Inc.$17.7M
TCRXTscan Therapeutics, Inc.$11.9M
TNGXTango Therapeutics, Inc.$9.7M
AMYTAmryt Pharma plc$6.2M
KURAKura Oncology, Inc.$5.7M
ATYRaTyr Pharma, Inc.$5.7M
CCXIChemoCentryx, Inc.$5.2M

Posizioni Chiuse (8)

TickerEmittenteNozionale
APLSApellis Pharmaceuticals, Inc.$143.6M
ADCTADC Therapeutics SA$34.5M
PTGXProtagonist Therapeutics, Inc.$20.4M
ISEEIVERIC bio, Inc.$8.9M
ASMBAssembly Biosciences, Inc.$8.2M
SPRYSilverback Therapeutics, Inc.$7.4M
CHMAChiasma, Inc.$6.7M
ORTXOrchard Therapeutics plc$5.2M

Aumentate (8)

TickerEmittenteNozionaleVar. Azioni
BLUEXXXXbluebird bio, Inc.$40.5M+1001.3%
TVTXTravere Therapeutics, Inc.$46.7M+991.3%
Apellis Pharmaceuticals, Inc.$29.5M+211.7%
CNTACentessa Pharmaceuticals plc$9.9M+181.8%
RLMDRelmada Therapeutics, Inc.$2.8M+162.4%
MGNXMacroGenics, Inc.$3.9M+120.5%
BMEABiomea Fusion, Inc.$1.7M+78.4%
KDNYChinook Therapeutics, Inc.$9.0M+76.1%

Ridotte (7)

TickerEmittenteNozionaleVar. Azioni
MREOMereo BioPharma Group plc$-7.1M-88.1%
BioMarin Pharmaceutical Inc.$-11.0M-70.0%
AUPHAurinia Pharmaceuticals Inc.$-3.0M-53.5%
NVAXNovavax, Inc.$-8.0M-24.3%
AMRNXXXXAmarin Corporation plc$-4.4M-17.4%
NVTAQInvitae Corporation$-65.0M-3.7%
OPTEYOpthea Limited$-0.0M-0.9%
← Torna agli Hedge Fund